Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Neoplasms metabolism"" wg kryterium: Temat


Tytuł :
Estudo metabolômico-alvo do fenótipo metabólico associado ao câncer de mama com ênfase no metabolismo do carbono-1
Targeted metabolomic study of metabolic phenotype associated with breast cancer with emphasis on one-carbon metabolism
Autorzy :
Jéssica Reis Santos
Pokaż więcej
Temat :
Carcinoma ductal
Metabolismo do carbono-1
Metabolômica
Neoplasias da mama
Tumor/metabolismo
Breast cancer
Metabolomics
Neoplasms/metabolism
One-carbon metabolism
Źródło :
Biblioteca Digital de Teses e Dissertações da USP
Universidade de São Paulo
Tytuł :
5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors
Autorzy :
Kristensen, Gitte
Strand, Siri H.
Røder, Martin Andreas
Berg, Kasper Drimer
Toft, Birgitte Grønkær
Høyer, Søren
Borre, Michael
Sørensen, Karina Dalsgaard
Brasso, Klaus
Pokaż więcej
Temat :
STRAIGHTFORWARD
predictive biomarkers
QD1-999
GLOBAL 5-HYDROXYMETHYLCYTOSINE
Multivariate Analysis
EPIGENETICS
Prostatic Neoplasms/metabolism
radical prostatectomy
OUTCOMES
DNA
ERG
PROTEIN EXPRESSION
Chemistry
Transcriptional Regulator ERG/metabolism
Aged
Middle Aged
5-Methylcytosine/analogs & derivatives
Article
QH301-705.5
5hmC
RECURRENCE
prostate cancer
ACTIVE-SURVEILLANCE
Cohort Studies
Prostatectomy
RISK
Journal Article
ROC Curve
Humans
REARRANGEMENT
Biology (General)
Male
Proportional Hazards Models
Źródło :
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 20, Iss 5, p 1025 (2019)
Kristensen, G, Strand, S, Røder, M A, Berg, K D, Toft, B G, Høyer, S, Borre, M, Sørensen, K D & Brasso, K 2019, ' 5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors ', International Journal of Molecular Sciences, vol. 20, no. 5, 1025 . https://doi.org/10.3390/ijms20051025
Kristensen, G, Strand, S H, Røder, M A, Berg, K D, Toft, B G, Høyer, S, Borre, M, Sørensen, K D & Brasso, K 2019, ' 5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors ', International Journal of Molecular Sciences, vol. 20, no. 5 . https://doi.org/10.3390/ijms20051025
Opis pliku :
application/pdf
Tytuł :
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
Autorzy :
Manara, Maria Cristina
Valente, Sergio
Cristalli, Camilla
Nicoletti, Giordano
Landuzzi, Lorena
Zwergel, Clemens
Mazzone, Roberta
Stazi, Giulia
Arimondo, Paola
Pasello, Michela
Guerzoni, Clara
Picci, Piero
Nanni, Patrizia
Lollini, Pier-Luigi
Mai, Antonello
Scotlandi, Katia
Pokaż więcej
Temat :
MESH: Animals
MESH: Osteosarcoma/drug therapy
MESH: Osteosarcoma/metabolism
MESH: Quinolines/chemistry
MESH: Male
MESH: DNA (Cytosine-5-)-Methyltransferase 1/genetics
MESH: Antineoplastic Combined Chemotherapy Protocols/therapeutic use
DNA Methyltransferase Inhibitor
MESH: Osteosarcoma/genetics
MESH: Aminoquinolines/pharmacology
MESH: Tumor Burden/genetics
chemotherapy
epigenetics
MESH: Aminoquinolines/administration & dosage
MESH: Doxorubicin/administration & dosage
MESH: Enzyme Inhibitors/chemistry
[SDV.CAN]Life Sciences [q-bio]/Cancer
MESH: Bone Neoplasms/drug therapy
MESH: Enzyme Inhibitors/administration & dosage
MESH: Enzyme Inhibitors/pharmacology
MESH: Xenograft Model Antitumor Assays
MESH: Bone Neoplasms/genetics
MESH: Benzamides/pharmacology
MESH: Tumor Burden/drug effects
MESH: Cisplatin/administration & dosage
MESH: Humans
MESH: Bone Neoplasms/metabolism
DNA methylation
MESH: Gene Expression Regulation, Neoplastic/drug effects
patient-derived xenograft (PDX)
MESH: Mice, Knockout
MESH: DNA (Cytosine-5-)-Methyltransferase 1/antagonists & inhibitors
MESH: DNA (Cytosine-5-)-Methyltransferase 1/metabolism
MESH: Benzamides/administration & dosage
[CHIM.THER]Chemical Sciences/Medicinal Chemistry
osteosarcoma
MESH: Cell Line, Tumor
Źródło :
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics, American Association for Cancer Research, 2018, 17 (9), pp.1881-1892. ⟨10.1158/1535-7163.MCT-17-0818⟩
Opis pliku :
STAMPA
Tytuł :
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
Autorzy :
Manara, Maria Cristina
Valente, Sergio
Cristalli, Camilla
Nicoletti, Giordano
Landuzzi, Lorena
Zwergel, Clemens
Mazzone, Roberta
Stazi, Giulia
Arimondo, Paola
Pasello, Michela
Guerzoni, Clara
Picci, Piero
Nanni, Patrizia
Lollini, Pier-Luigi
Mai, Antonello
Scotlandi, Katia
Pokaż więcej
Temat :
MESH: Aminoquinolines/administration & dosage
MESH: Aminoquinolines/pharmacology
MESH: Cisplatin/administration & dosage
MESH: DNA (Cytosine-5-)-Methyltransferase 1/antagonists & inhibitors
MESH: DNA (Cytosine-5-)-Methyltransferase 1/genetics
MESH: DNA (Cytosine-5-)-Methyltransferase 1/metabolism
MESH: Doxorubicin/administration & dosage
MESH: Enzyme Inhibitors/administration & dosage
MESH: Enzyme Inhibitors/chemistry
MESH: Enzyme Inhibitors/pharmacology
MESH: Gene Expression Regulation, Neoplastic/drug effects
MESH: Humans
MESH: Animals
MESH: Male
MESH: Mice, Knockout
MESH: Osteosarcoma/drug therapy
MESH: Osteosarcoma/genetics
MESH: Osteosarcoma/metabolism
MESH: Quinolines/chemistry
MESH: Tumor Burden/drug effects
MESH: Tumor Burden/genetics
MESH: Xenograft Model Antitumor Assays
MESH: Antineoplastic Combined Chemotherapy Protocols/therapeutic use
MESH: Benzamides/administration & dosage
MESH: Benzamides/pharmacology
MESH: Bone Neoplasms/drug therapy
MESH: Bone Neoplasms/genetics
MESH: Bone Neoplasms/metabolism
MESH: Cell Line, Tumor
[CHIM.THER]Chemical Sciences/Medicinal Chemistry
[SDV.CAN]Life Sciences [q-bio]/Cancer
Źródło :
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics, American Association for Cancer Research, 2018, 17 (9), pp.1881-1892. ⟨10.1158/1535-7163.MCT-17-0818⟩

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies